How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study.
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study. — المؤلف: Birkeland, Kåre I — Diabetes, obesity & metabolism 20200907
- المؤلف
- Birkeland, Kåre I
- النشر
- Diabetes, obesity & metabolism 20200907
- الوصف
- 968-974 p.
- الموضوعات
- Aged؛ Aged, 80 and over؛ Cardiovascular Diseases؛ Clinical Trials as Topic؛ Diabetes Mellitus, Type 2؛ Female؛ Germany؛ Humans